Jae Il KIM,San Ho KIM,Seon Myung KIM,Moon Young PARK
申请号:
US15127512
公开号:
US20170128541A1
申请日:
2015.03.23
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention relates to a novel exenatide analogue, which is an exenatide analogue in which the first to fifteenth amino acids from the C-terminal of the amino acid sequence of exenatide are deleted and a fatty acid is conjugated. The present invention provides a short length exenatide exhibiting almost the same level of anti-diabetic effects compared with that of conventional exenatide and liraglutide, which is an anti-diabetic drug, and capable of reducing the preparation cost of exenatide.